Gap junctions and cancer: New functions for an old story

Antioxidants and Redox Signaling

Volumn 11, Issue 2, 2009, Pages 323-338

  Cronier, Laurent ^a   Crespin, Sophie ^a   Strale, Pierre Olivier ^a   Defamie, Norah ^a   Mesnil, Marc ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GAP JUNCTION PROTEIN;

ANGIOGENESIS; BRAIN DEVELOPMENT; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL ADHESION; CELL COMMUNICATION; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GAP JUNCTION; GENE EXPRESSION; GLIOMA; HUMAN; METASTASIS; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; REVIEW; SKIN CANCER; STROMA; TUMOR GROWTH;

CELL COMMUNICATION; CONNEXINS; GAP JUNCTIONS; GENE EXPRESSION REGULATION, NEOPLASTIC; NEOPLASMS;

EID: 58149104029     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2153     Document Type: Review

References (123)

1. Ai Z, Fischer A, Spray DC, Brown AM, and Fishman GI. Wnt-1 regulation of connexin43 in cardiac myocytes. J Clin Invest 105: 161-171, 2000.
2. Avanzo JL, Mesnil M, Hernandez-Blazquez FJ, Mackowiak II, Mori CM, da Silva TC, Oloris SC, Gárate AP, Massironi SM, Yamasaki H, and Dagli ML. Increased susceptibility to urethane-induced lung tumors in mice with decreased expression of connexin43. Carcinogenesis 25: 1973-1982, 2004.
3. Bates DC, Sin WC, Aftab Q, and Naus CC. Connexin43 enhances glioma invasion by a mechanism involving the carboxy terminus. Glia 55: 1554-1564, 2007.
4. Bee A, Ke Y, Forootan S, Lin K, Beesley C, Forrest SE, and Foster CS. Ribosomal protein L19 is a prognostic marker for human prostate cancer. Clin Cancer Res 12: 2061-2065, 2006.
5. Bond SL, Bechberger JF, Khoo NK, and Naus CC. Transfection of C6 glioma cells with connexin32: the effects of expression of a nonendogenous gap junction protein. Cell Growth Differ 5: 179-186, 1994.
6. Bradshaw SL, Naus CC, Zhu D, Kidder GM, and Han VK. Insulin-like growth factor binding protein-4 gene expression is induced by transfection of gap junction connexin43 gene in a C6 glioma cell line. Growth Regul 3: 26-29, 1993.
7. Bräuner T and Hülser DF. Tumor cell invasion and gap junctional communication. II. Normal and malignant cells confronted in multicell spheroids. Invasion Metastasis 10: 31-48, 1990.
8. Chen SC, Pelletier DB, Ao P, and Boynton AL. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases. Cell Growth Differ 6: 681-690, 1995.
9. Crespin S, Defamie N, Cronier L, and Mesnil M. Involvements of connexins in carcinogenesis. In: Connexins: a guide, edited by Harris A and Locke D. Tonawa, NJ: Humana Press, 2009, in press.
10. Cronier L, Defamie N, Dupays L, Theveniau-Ruissy M, Goffin F, Pointis G, and Malassine A. Connexin expression and gap junctional intercellular communication in human first trimester trophoblast. Mol Hum Reprod 8: 1005-1013, 2002.
11. Dang X, Doble BW, and Kardami E. The carboxy-tail of connexin43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 242: 35-38, 2003.
12. Dang X, Jeyaraman M, and Kardami E. Regulation of connexin43-mediated growth inhibition by a phosphorylatable amino-acid is independent of gap junction-forming ability. Mol Cell Biochem 289: 201-217, 2006.
13. de Feijter AW, Matesic DF, Ruch RJ, Guan X, Chang CC, and Trosko JE. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells. Mol Carcinog 16: 203-212, 1996.
14. Duffy HS, Iacobas I, Hotchkiss K, Hirst-Jensen BJ, Bosco A, Dandachi N, Dermietzel R, Sorgen PL, and Spray DC. The gap junction protein connexin32 interacts with the Src homology 3/hook domain of discs large homolog 1. J Biol Chem 282: 9789-9796, 2007.
15. Duflot-Dancer A, Mesnil M, and Yamasaki H. Dominant-negative abrogation of connexin-mediated cell growth control by mutant connexin genes. Oncogene 15: 2151-2158, 1997.
16. Elias LAB, Wang DD, and Kriegstein AR. Gap junction adhesion is necessary for radial migration in the neocortex. Nature 448: 901-907, 2007.
17. El-Sabban ME and Pauli BU. Adhesion-mediated gap junctional communication between lung-metastatic cancer cells and endothelium. Invasion Metastasis 14: 164-176, 1994-1995.
18. Flachon V, Tonoli H, Selmi-Ruby S, Durand C, Rabilloud R, Rousset B, and Munari-Silem Y. Thyroid cell proliferation in response to forced expression of gap junction proteins. Eur J Cell Biol 81: 243-252, 2002.
19. Fu CT, Bechberger JF, Ozog MA, Perbal B, and Naus CC. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J Biol Chem 279: 36943-36950, 2004.
20. Fujimoto E, Satoh H, Negishi E, Ueno K, Nagashima Y, Hagiwara K, Yamasaki H, and Yano T. Negative growth control of renal cell carcinoma cell by connexin 32: possible involvement of Her-2. Mol Carcinog 40: 135-142, 2004.
21. Fushiki S, Perez Velazquez JL, Zhang L, Bechberger JF, Carlen PL, and Naus CC. Changes in neuronal migration in neocortex of connexin43 null mutant mice. J Neuropathol Exp Neurol 62: 304-314, 2003.
22. Gellhaus A, Dong X, Propson S, Maass K, Klein-Hitpass L, Kibschull M, Traub O, Willecke K, Perbal B, Lye SJ, and Winterhager E. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 279: 36931-36942, 2004.
23. Goetz DJ, el-Sabban ME, Hammer DA, and Pauli BU. Lu-ECAM-1-mediated adhesion of melanoma cells to endothelium under conditions of flow. Int J Cancer 65: 192-199, 1996.
24. Goldberg GS, Lampe PD, and Nicholson BJ. Selective transfer of endogenous metabolites through gap junctions composed of different connexins. Nat Cell Biol 1: 457-459, 1999.
25. Goldberg GS, Bechberger JF, Tajima Y, Merritt M, Omori Y, Gawinowicz MA, Narayanan R, Tan Y, Sanai Y, Yamasaki H, Naus CC, Tsuda H, and Nicholson BJ. Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res 60: 6018-6026, 2000.
26. Goldberg GS, Moreno AP, and Lampe PD. Gap junctions between cells expressing connexin 43 or 32 show inverse permselectivity to adenosine and ATP. J Biol Chem 277: 36725-36730, 2002.
27. Graeber SH and Hülser DF. Connexin transfection induces invasive properties in HeLa cells. Exp Cell Res 243: 142-149, 1998.
28. Gupta N, Wang H, McLeod TL, Naus CC, Kyurkchiev S, Advani S, Yu J, Perbal B, and Weichselbaum RR. Inhibition of glioma cell growth and tumorigenic potential by CCN3 (NOV). Mol Pathol 54: 293-299, 2001.
29. Hamada J, Takeichi N, and Kobayashi H. Metastatic capacity and intercellular communication between normal cells and metastatic cell clones derived from a rat mammary carcinoma. Cancer Res 48: 5129-5132, 1988.
30. Hamada J, Takeichi N, Ren J, and Kobayashi H. Junctional communication of highly and weakly metastatic variant clones from a rat mammary carcinoma in primary and metastatic sites. Invasion Metastasis 11: 149-157, 1991.
31. Henry JL, Coggin DL, and King CR. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2. Cancer Res 53:1403-1408, 1993.
32. Hervé JC, Bourmeyster N, and Sarrouilhe D. Diversity in protein-protein interactions of connexins: emerging roles. Biochim Biophys Acta 1662: 22-41, 2004.
33. Hirschi KK, Xu CE, Tsukamoto T, and Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ 7: 861-870, 1996.
34. Hsueh YP. The role of the MAGUK protein CASK in neural development and synaptic function. Curr Med Chem 13: 1915-1927, 2006.
35. Huang R, Fan Y, Hossain MZ, Peng A, Zeng ZL, and Boynton AL. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43). Cancer Res 58: 5089-5096, 1998.
36. Huang GY, Cooper ES, Waldo K, Kirby ML, Gilula NB, and Lo CW. Gap junction-mediated cell-cell communication modulates mouse neural crest migration. J Cell Biol 143: 1725-1734, 1998.
37. Huang GY, Wessels A, Smith BR, Linask KK, Ewart JL, and Lo CW. Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev Biol 198: 32-44, 1998.
38. Huang R, Lin Y, Wang CC, Gano J, Lin B, Shi Q, Boynton A, Burke J, and Huang RP. Connexin 43 suppresses human glioblastoma cell growth by down-regulation of monocyte chemotactic protein 1, as discovered using protein array technology. Cancer Res 62: 2806-2812, 2002.
39. Huanga CJ, Chien CC, Yang SH, Chang CC, Sun HL, Cheng YC, Liu CC, Lin SC, and Lin CM. Fecal ribosomal protein L19 is a genetic prognostic factor for survival in colorectal cancer. J Cell Mol Med 2008, in press.
40. Iacobas DA, Urban-Maldonado M, Iacobas S, Scemes E, and Spray DC. Array analysis of gene expression in connexin43 null astrocytes. Physiol Genomics 15: 177-190, 2003.
41. Iacobas DA, Scemes E, and Spray DC. Gene expression alterations in connexin null mice extend beyond the gap junction. Neurochem Int 45: 243-250, 2004.
42. Ito A, Katoh F, Kataoka TR, Okada M, Tsubota N, Asada H, Yoshikawa K, Maeda S, Kitamura Y, Yamasaki H, and Nojima H. A role for heterologous gap junctions between melanoma and endothelial cells in metastasis. J Clin Invest 105: 1189-1197, 2000.
43. Ito A, Morita N, Miura D, Koma Y, Kataoka TR, Yamasaki H, Kitamura Y, Kita Y, and Nojima H. A derivative of oleamide potently inhibits the spontaneous metastasis of mouse melanoma BL6 cells. Carcinogenesis 25: 2015-2022, 2004.
44. Ito A, Koma Y, Uchino K, Okada T, Ohbayashi C, Tsubota N, and Okada M. Increased expression of connexin 26 in the invasive component of lung squamous cell carcinoma: significant correlation with poor prognosis. Cancer Lett 234: 239-248, 2006.
45. Juneja SC, Barr KJ, Enders GC, and Kidder GM. Defects in the germ line and gonads of mice lacking connexin43. Biol Reprod 60: 1263-1270, 1999.
46. Kalra J, Shao Q, Qin H, Thomas T, Alaoui-Jamali MA, and Laird DW. Cx26 inhibits breast MDA-MB-435 cell tumorigenic properties by a gap junctional intercellular communication-independent mechanism. Carcinogenesis 27: 2528-2537, 2006.
47. Kamei J, Toyofuku T, and Hori M. Negative regulation of p21 by beta-catenin/TCF signalling: a novel mechanism by which cell adhesion molecules regulate cell proliferation. Biochem Biophys Res Commun 312: 380-387, 2003.
48. Kamibayashi Y, Oyamada Y, Mori M, and Oyamada M. Aberrant expression of gap junction proteins (connexins) is associated with tumor progression during multistage mouse skin carcinogenesis in vivo. Carcinogenesis 16: 1287-1297, 1995.
49. Kanczuga-Koda L, Sulkowski S, Koda M, and Sulkowska M. Alterations in connexin26 expression during colorectal carcinogenesis. Oncology 68: 217-222, 2005.
50. Kanczuga-Koda L, Sulkowski S, Lenczewski A, Koda M, Wincewicz A, Baltaziak M, and Sulkowska M. Increased expression of connexins 26 and 43 in lymph node metastases of breast cancer. J Clin Pathol 59: 429-433, 2006.
51. Kanemitsu MY, Jiang W, and Eckhart W. Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ 9: 13-21, 1998.
52. Kapoor P, Saunders MM, Li Z, Zhou Z, Sheaffer N, Kunze EL, Samant RS, Welch DR, and Donahue HJ. Breast cancer metastatic potential: correlation with increased heterotypic gap junctional intercellular communication between breast cancer cells and osteoblastic cells. Int J Cancer 111: 693-697, 2004.
53. Kardami E, Dang X, Iacobas DA, Nickel BE, Jeyaraman M, Srisakuldee W, Makazan J, Tanguy S, and Spray DC. The role of connexins in controlling cell growth and gene expression. Prog Biophys Mol Biol 94: 245-264, 2007.
54. Kaufmann P and Castelucci M. Extravillous trophoblast in the human placenta: a review. Trophobl Res 10: 21-65, 1997.
55. Koffler L, Roshong S, Kyu Park I, Cesen-Cummings K, Thompson DC, Dwyer-Nield LD, Rice P, Mamay C, Malkinson AM, and Ruch RJ. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1) after forced connexin expression in lung and liver carcinoma cells. J Cell Biochem 79: 347-354, 2000.
56. Krutovskikh VA, Troyanovsky SM, Piccoli C, Tsuda H, Asamoto M, and Yamasaki H. Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo. Oncogene 19 : 505-513, 2000.
57. Lampe PD, Kurata WE, Warn-Cramer BJ, and Lau AF. Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J Cell Sci 111: 833-841, 1998.
58. Lampe PD and Lau AF. The effects of connexin phosphorylation on gap junctional communication. Int J Biochem Cell Biol 36: 1171-1186, 2004.
59. Larocca D, Peterson JA, Urrea R, Kuniyoshi J, Bistrain AM, and Ceriani RL. A Mr 46,000 human milk fat globule protein that is highly expressed in human breast tumors contains factor VIII-like domains. Cancer Res 51: 4994-4998, 1991.
60. Lecanda F, Warlow PM, Sheikh S, Furlan F, Steinberg TH, and Civitelli R. Connexin43 deficiency causes delayed ossification, craniofacial abnormalities, and osteoblast dysfunction. J Cell Biol 151: 931-944, 2000.
61. Li Q, Omori Y, Nishikawa Y, Yoshioka T, Yamamoto Y, and Enomoto K. Cytoplasmic accumulation of connexin32 protein enhances motility and metastatic ability of human hepatoma cells in vitro and in vivo. Int J Cancer 121: 536-546, 2007.
62. Lin JH, Takano T, Cotrina ML, Arcuino G, Kang J, Liu S, Gao Q, Jiang L, Li F, Lichtenberg-Frate H, Haubrich S, Willecke K, Goldman SA, and Nedergaard M. Connexin 43 enhances the adhesivity and mediates the invasion of malignant glioma cells. J Neurosci 22: 4302-4311, 2002.
63. Lo CW and Wessels A. Cx43 gap junctions in cardiac development. Trends Cardiovasc Med 8: 264-269, 1998.
64. Loewenstein WR. Junctional intercellular communication and the control of growth. Biochim Biophys Acta 560: 1-65, 1979.
65. Malassiné A and Cronier L. Involvement of gap junctions in placental functions and development. Biochim Biophys Acta 1719: 117-124, 2005.
66. Martyn KD, Kurata WE, Warn-Cramer BJ, Bun JM, TenBroek E, and Lau AF. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype. Cell Growth Differ 8: 1015-1027, 1997.
67. McLachlan E, Shao Q, Wang HL, Langlois S, and Laird DW. Connexins act as tumor suppressors in three-dimensional mammary cell organoids by regulating differentiation and angiogenesis. Cancer Res 66: 9886-9894, 2006.
68. Melchheier I, von Montfort C, Stuhlmann D, Sies H, and Klotz LO. Quinone-induced Cdc25A inhibition causes ERK-dependent connexin phosphorylation. Biochem Biophys Res Commun 327: 1016-1023, 2005.
69. Mesnil M, Krutovskikh V, Piccoli C, Elfgang C, Traub O, Willecke K, and Yamasaki H. Negative growth control of HeLa cells by connexin genes: connexin species specificity. Cancer Res 55: 629-639, 1995.
70. Mesnil M, Crespin S, Avanzo JL, and Zaidan-Dagli ML. Defective gap junctional intercellular communication in the carcinogenic process. Biochim Biophys Acta 1719: 125-145, 2005.
71. Mehta PP, Perez-Stable C, Nadji M, Mian M, Asotra K, and Roos BA. Suppression of human prostate cancer cell growth by forced expression of connexin genes. Dev Genet 24: 91-110, 1999.
72. Miekus K, Czernik M, Sroka J, Czyz J, and Madeja Z. Contact stimulation of prostate cancer cell migration: the role of gap junctional coupling and migration stimulated by heterotypic cell-to-cell contacts in determination of the metastatic phenotype of Dunning rat prostate cancer cells. Biol Cell 97: 893-903, 2005.
73. Moorby C and Patel M. Dual functions for connexins: Cx43 regulates growth independently of gap junction formation. Exp Cell Res 271: 238-248, 2001.
74. Nagasawa K, Chiba H, Fujita H, Kojima T, Saito T, Endo T, and Sawada N. Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol 208: 123-132, 2006
75. Nakase T and Naus CG. Gap junctions and neurological disorders of the central nervous system. Biochim Biophys Acta 1662: 215-224, 2004.
76. Naus CC, Bond SL, Bechberger JF, and Rushlow W. Identification of genes differentially expressed in C6 glioma cells transfected with connexin43. Brain Res Brain Res Rev 32: 259-266, 2000.
77. Naus CCG. Gap junctions and tumour progression. Can J Physiol Pharmacol 80: 136-141, 2002.
78. Nicolson GL, Dulski KM, and Trosko JE. Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells. Proc Natl Acad Sci U S A 85: 473-476, 1988.
79. Nishimura T, Dunk C, Lu Y, Feng X, Gellhaus A, Winterhager E, Rossant J, and Lye SJ. Gap junctions are required for trophoblast proliferation in early human placental development. Placenta 25: 595-607, 2004.
80. Olbina G and Eckhart W. Mutations in the second extracellular region of connexin 43 prevent localization to the plasma membrane, but do not affect its ability to suppress cell growth. Mol Cancer Res 1: 690-700, 2003.
81. Oliveira R, Christov C, Guillamo JS, de Boüard S, Palfi S, Venance L, Tardy M, and Peschanski M. Contribution of gap junctional communication between tumor cells and astroglia to the invasion of the brain parenchyma by human glioblastomas. BMC Cell Biol 6: 7, 2005.
82. Omori Y, Li Q, Nishikawa Y, Yoshioka T, Yoshida M, Nishimura T, and Enomoto K. Pathological significance of intracytoplasmic connexin proteins: implication in tumor progression. J Membr Biol 218: 73-77, 2007.
83. Penes MC, Li X, and Nagy JI. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur J Neurosci 22: 404-418, 2005.
84. Peterson JA, Couto JR, Taylor MR, and Ceriani RL. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer. Cancer Res 55: 5847s-5851s, 1995.
85. Pimentel RC, Yamada KA, Kléber AG, and Saffitz JE. Autocrine regulation of myocyte Cx43 expression by VEGF. Circ Res 90: 671-677, 2002.
86. Pollmann MA, Shao Q, Laird DW, and Sandig M. Connexin 43 mediated gap junctional communication enhances breast tumor cell diapedesis in culture. Breast Cancer Res 7: R522-R534, 2005.
87. Princen F, Robe P, Gros D, Jarry-Guichard T, Gielen J, Merville MP, and Bours V. Rat gap junction connexin-30 inhibits proliferation of glioma cell lines. Carcinogenesis 22: 507-513, 2001.
88. Proulx AA, Lin ZX, and Naus CC. Transfection of rhabdomyosarcoma cells with connexin43 induces myogenic differentiation. Cell Growth Differ 8: 533-540, 1997.
89. Proulx A, Merrifield PA, and Naus CC. Blocking gap junctional intercellular communication in myoblasts inhibits myogenin and MRF4 expression. Dev Genet 20: 133-144, 1997.
90. Qin H, Shao Q, Thomas T, Kalra J, Alaoui-Jamali MA, and Laird DW. Connexin26 regulates the expression of angiogenesis-related genes in human breast tumor cells by both GJIC-dependent and -independent mechanisms. Cell Commun Adhes 10: 387-393, 2003.
91. Reaume AG, de Sousa PA, Kulkarni S, Langille BL, Zhu D, Davies TC, Juneja SC, Kidder GM, and Rossant J. Cardiac malformation in neonatal mice lacking connexin43. Science 267: 1831-1834, 1995.
92. Ren J, Hamada J, Takeichi N, Fujikawa S, and Kobayashi H. Ultrastructural differences in junctional intercellular communication between highly and weakly metastatic clones derived from rat mammary carcinoma. Cancer Res 50: 358-362, 1990.
93. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sáez PJ, Sáez JC, and Giaume C. Cx43 hemichannels and gap junction channels in astrocytes are regulated oppositely by proinflammatory cytokines released from activated microglia. J Neurosci 27: 13781-13792, 2007.
94. Rose B, Mehta PP, and Loewenstein WR. Gap-junction protein gene suppresses tumorigenicity. Carcinogenesis 14: 1073-1075, 1993.
95. Ruch RJ and Trosko JE. Gap-junction communication in chemical carcinogenesis. Drug Metab Rev 33: 117-124, 2001.
96. Saez JC, Retamal MA, Basilio D, Bukauskas FF, and Bennett MVL. Connexin-based gap junction hemichannels: gating mechanisms. Biochim Biophys Acta 1711: 215-224, 2005.
97. Saito-Katsuragi M, Asada H, Niizeki H, Katoh F, Masuzawa M, Tsutsumi M, Kuniyasu H, Ito A, Nojima H, and Miyagawa S. Role for connexin 26 in metastasis of human malignant melanoma: communication between melanoma and endothelial cells via connexin 26. Cancer 110: 1162-1172, 2007.
98. Saunders MM, Seraj MJ, Li Z, Zhou Z, Winter CR, Welch DR, and Donahue HJ. Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. Cancer Res 61: 1765-1767, 2001.
99. Shao Q, Wang H, McLachlan E, Veitch GI, and Laird DW. Down-regulation of Cx43 by retroviral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res 65: 2705-2711, 2005.
100. Shoji A, Sakamoto Y, Tsuchiya T, Moriyama K, Kaneko T, Okubo T, Umeda M, and Miyazaki K. Inhibition of tumor promoter activity toward mouse fibroblasts and their in vitro transformation by tissue inhibitor of metalloproteinases-1 (TIMP-1). Carcinogenesis 18: 2093-2100, 1997.
101. Solan JL, Fry MD, TenBroek EM, and Lampe PD. Connexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. J Cell Sci 116: 2203-2211, 2003.
102. Stains JP and Civitelli R. Cell-to-cell interactions in bone. Biochem Biophys Res Commun 328: 721-727, 2005.
103. Suarez S and Ballmer-Hofer K. VEGF transiently disrupts gap junctional communication in endothelial cells. J Cell Sci 114: 1229-1235, 2001.
104. Tate AW, Lung T, Radhakrishnan A, Lim SD, Lin X, and Edlund M. Changes in gap junctional connexin isoforms during prostate cancer progression. Prostate 66: 19-31, 2006.
105. Temme A, Buchmann A, Gabriel HD, Nelles E, Schwarz M, and Willecke K. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 7: 713-716, 1997.
106. Trosko JE and Ruch RJ. Cell-cell communication in carcinogenesis. Front Biosci 3: 208-236, 1998.
107. Trosko JE and Ruch RJ. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets 3: 465-482, 2002.
108. Upham BL, Suzuki J, Chen G, Wang Y, McCabe LR, Chang CC, Krutovskikh VA, Yamasaki H, and Trosko JE. Reduced gap junctional intercellular communication and altered biological effects in mouse osteoblast and rat liver oval cell lines transfected with dominant-negative connexin 43. Mol Carcinog 37: 192-201, 2003.
109. Weissman TA, Riquelme PA, Ivic L, Flint AC, and Kriegstein AR. Calcium waves propagate through radial glial cells and modulate proliferation in the developing neocortex. Neuron 43: 647-661, 2004.
110. Willecke K, Eiberger J, Degen J, Eckardt D, Romualdi A, Güldenagel M, Deutsch U, and Söhl G. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 383: 725-737, 2002.
111. Winterhager E, Von Ostau C, Gerke M, Gruemmer R, Traub O, and Kaufmann P. Connexin expression patterns in human trophoblast cells during placental development. Placenta 20: 627-638, 1999.
112. Xie H, Laird DW, Chang TH, and Hu VW. A mitosis-specific phosphorylation of the gap junction protein connexin43 in human vascular cells: biochemical characterization and localization. J Cell Biol 137: 203-210, 1997.
113. Xu X, Li WE, Huang GY, Meyer R, Chen T, Luo Y, Thomas MP, Radice GL, and Lo CW. N-cadherin and Cx43alpha1 gap junctions modulates mouse neural crest cell motility via distinct pathways. Cell Commun Adhes 8: 321-324, 2001.
114. Xu X, Francis R, Wei CJ, Linask KL, and Lo CW. Connexin 43-mediated modulation of polarized cell movement and the directional migration of cardiac neural crest cells. Development 133: 3629-3639, 2006.
115. Yamasaki H and Naus CC. Role of connexin genes in growth control. Carcinogenesis 17: 1199-1213, 1996.
116. Zhang W, Couldwell WT, Simard MF, Song H, Lin JH, and Nedergaard M. Direct gap junction communication between malignant glioma cells and astrocytes. Cancer Res 59: 1994-2003, 1999.
117. Zhang YW, Morita I, Ikeda M, Ma KW, and Murota S. Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27. Oncogene 20: 4138-4149, 2001.
118. Zhang YW, Kaneda M, and Morita I. The gap junction-independent tumor-suppressing effect of connexin 43. J Biol Chem 278: 44852-44856, 2003.
119. Zhang YW, Nakayama K, Nakayama K, and Morita I, A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinase-associated protein (Skp 2). Cancer Res 63: 1623-1630, 2003.
120. Zhang W, Nwagwu C, Le DM, Yong VW, Song H, and Couldwell WT. Increased invasive capacity of connexin43-overexpressing malignant glioma cells. J Neurosurg 99: 1039-1046, 2003.
121. Zhang W, DeMattia JA, Song H, and Couldwell WT. Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J Neurosurg 98: 846-853, 2003.
122. Zhu D, Caveney S, Kidder GM, and Naus CC. Transfection of C6 glioma cells with connexin 43 cDNA: analysis of expression, intercellular coupling, and cell proliferation. Proc Natl Acad Sci U S A 88: 1883-1887, 1991.
123. Zhu D, Cheng CF, and Pauli BU. Blocking of lung endothelial cell adhesion molecule-1 (Lu-ECAM-1) inhibits murine melanoma lung metastasis. J Clin Invest 89:1718-1724, 1992.